Bio-Techne
TECH
#1488
Rank
C$16.66 B
Marketcap
$104.89
Share price
0.40%
Change (1 day)
1.51%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : C$0.85 Billion

According to Bio-Techne's latest financial reports the company's total liabilities are C$0.85 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Bio-Techne - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-06-30C$0.88 B16.38%
2022-06-30C$0.76 B-10.93%
2021-06-30C$0.85 B-2.46%
2020-06-30C$0.87 B-6.75%
2019-06-30C$0.94 B39.55%
2018-06-30C$0.67 B-14.49%
2017-06-30C$0.79 B142.87%
2016-06-30C$0.32 B21.51%
2015-06-30C$0.26 B273.63%
2014-06-30C$71.7 M68.06%
2013-06-30C$42.66 M-6.64%
2012-06-30C$45.69 M49.23%
2011-06-30C$30.62 M70.52%
2010-06-30C$17.95 M-0.02%
2009-06-30C$17.96 M-12.87%
2008-06-30C$20.61 M13.12%
2007-06-30C$18.22 M-45.58%
2006-06-30C$33.49 M-0.07%
2005-06-30C$33.51 M-11.1%
2004-06-30C$37.7 M4.98%
2003-06-30C$35.91 M-25.34%
2002-06-30C$48.09 M-16.15%
2001-06-30C$57.36 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
C$73.63 B 8,481.83%๐Ÿ‡บ๐Ÿ‡ธ USA
C$4.47 B 421.56%๐Ÿ‡บ๐Ÿ‡ธ USA
C$45.09 B 5,155.90%๐Ÿ‡บ๐Ÿ‡ธ USA
C$42.09 B 4,806.53%๐Ÿ‡บ๐Ÿ‡ธ USA
C$3.93 B 358.71%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
C$154.53 B 17,911.54%๐Ÿ‡บ๐Ÿ‡ธ USA
C$39.68 M-95.37%๐Ÿ‡บ๐Ÿ‡ธ USA